Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription 19.01.2026 15 Alzheimers Dement 1 Brain Res 1 Curr Treat Options Neurol 1 Dement Geriatr Cogn Disord 1 Exp Neurol 9 J Alzheimers Dis 1 J Neurosci 2 Neurobiol Dis 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. RUSSELL JK, Schlachetzki Z, Conley AC, Boyd BD, et al
   Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study.
   Alzheimers Dement. 2026;22:e71028.
   PubMed         Abstract available
   
   
2. CHENG Q, Nolz J, Karr T, Dorn N, et al
   Gut proteome and microbiome alterations: Analysis of transverse colon samples from pathologically confirmed Alzheimer's disease patients.
   Alzheimers Dement. 2026;22:e71021.
   PubMed         Abstract available
   
   
3. RICHARDSON TI, Klein RC, Huang K, Zhang J, et al
   Next-generation Alzheimer's therapeutics: target assessment and enablement at the Indiana University School of Medicine-Purdue University TREAT-AD Center.
   Alzheimers Dement. 2026;22:e70964.
   PubMed         Abstract available
   
   
4. TRAMMELL AR, Dorbin CD, Davis CP, Manzanares CM, et al
   Successful strategies for supporting diverse representation in Alzheimer's disease research.
   Alzheimers Dement. 2026;22:e70941.
   PubMed         Abstract available
   
   
5. ALASMAR Z, Tremblay C, Moqadam R, Serrano GE, et al
   Gray matter microstructure from in vivo diffusion magnetic resonance imaging reflects post mortem neuropathology severity and clinical progression of Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71037.
   PubMed         Abstract available
   
   
6. COLEMAN PD, Delvaux E, Boehringer A, Huseby CJ, et al
   Regarding the importance of population diversity validation in Alzheimer's disease models.
   Alzheimers Dement. 2026;22:e71071.
   PubMed        
   
   
7. RUDROFF T
   Population diversity validation for Alzheimer's disease "unifying" models.
   Alzheimers Dement. 2026;22:e71070.
   PubMed        
   
   
8. PENTCHEV JV, Jackson T, Khan N, Rosewood TJ, et al
   Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71066.
   PubMed         Abstract available
   
   
9. ZENG X, Deek RA, Nafash MN, Gu JM, et al
   Biomarkers.
   Alzheimers Dement. 2025;21 Suppl 2.
   PubMed         Abstract available
   
   
10. ALI A, DeLong A, Williams LA, Henry AP, et al
    Lessons learned in the recruitment and retention of Black males in informal dementia caregiving research.
    Alzheimers Dement. 2026;22:e70939.
    PubMed         Abstract available
    
    
11. YASKOLKA MEIR A, Wang X, Tasaki S, Sarsani V, et al
    Brain-peripheral proteome crosstalk in Alzheimer's disease with and without diabetes mellitus.
    Alzheimers Dement. 2026;22:e70959.
    PubMed         Abstract available
    
    
12. HIBAR DP, Bauer A, Rabe C, Borlinghaus N, et al
    Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts.
    Alzheimers Dement. 2026;22:e71009.
    PubMed         Abstract available
    
    
13. HERD P, Sicinski K, Williams V, Asthana S, et al
    Early-life influences on the risk for later-life Alzheimer's and non-Alzheimer's dementia: A nearly full life course prospective cohort study.
    Alzheimers Dement. 2026;22:e70967.
    PubMed         Abstract available
    
    
14. CHOI KY, Kang S, Cook S, Li D, et al
    The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study.
    Alzheimers Dement. 2026;22:e70981.
    PubMed         Abstract available
    
    
15. DURANT A, Mukherjee S, Lee ML, Choi SE, et al
    Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgers.
    Alzheimers Dement. 2026;22:e71024.
    PubMed         Abstract available
    
    

    
    Brain Res

16. CADAXO AS, Cotrin JC, Valente AP, Lopes FG, et al
    Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort.
    Brain Res. 2026;1874:150167.
    PubMed         Abstract available
    
    

    
    Curr Treat Options Neurol

17. THALIATH A, Pillai JA
    Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.
    Curr Treat Options Neurol. 2025;27:41.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

18. BARCZAK A, Krempa-Kowalewska A
    Validation of the Polish version of Addenbrooke's Cognitive Examination III in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Dement Geriatr Cogn Disord. 2026 Jan 13:1-16. doi: 10.1159/000549856.
    PubMed         Abstract available
    
    

    
    Exp Neurol

19. VAN ROOIJ JRA, van den Berg M, Van Vosselen M, Calus E, et al
    Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimer's disease.
    Exp Neurol. 2026 Jan 14:115647. doi: 10.1016/j.expneurol.2026.115647.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

20. THORNTON JM, Stevenson JL
    Mites, microbes, and neurodegeneration: A unified environmental hypothesis for Parkinson's disease, Alzheimer's disease, and Lewy body dementia.
    J Alzheimers Dis. 2026 Jan 13:13872877251412923. doi: 10.1177/13872877251412923.
    PubMed         Abstract available
    
    
21. YUAN J, Hu Y, Feng F, Hou B, et al
    Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohort.
    J Alzheimers Dis. 2026 Jan 13:13872877251411413. doi: 10.1177/13872877251411413.
    PubMed         Abstract available
    
    
22. ANDIN U, Lifvergren S, Zetterberg H, Blennow K, et al
    Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia.
    J Alzheimers Dis. 2026 Jan 13:13872877251411336. doi: 10.1177/13872877251411336.
    PubMed         Abstract available
    
    
23. TEIPEL S, Konig A, Brem AK, Perry G, et al
    Recommendations for reporting findings from analyses using artificial intelligence and machine learning in the Journal of Alzheimer's Disease.
    J Alzheimers Dis. 2026 Jan 13:13872877251413701. doi: 10.1177/13872877251413701.
    PubMed         Abstract available
    
    
24. YANG Y, Kwak YT
    Neuropsychiatric signs and symptoms clusters and regional amyloid on (18)F-FC119S PET in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 13:13872877251411433. doi: 10.1177/13872877251411433.
    PubMed         Abstract available
    
    
25. ALKAM T, Tarshizi E, Van Benschoten AH
    Flagging high-risk comorbidities in Alzheimer's disease emergency department visits: A machine learning analysis of mortality outcomes.
    J Alzheimers Dis. 2026 Jan 13:13872877251409332. doi: 10.1177/13872877251409332.
    PubMed         Abstract available
    
    
26. HEO RJ, Negida A, Barrett MJ, Chrenka EA, et al
    Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment.
    J Alzheimers Dis. 2026 Jan 13:13872877251411418. doi: 10.1177/13872877251411418.
    PubMed         Abstract available
    
    
27. WANG X, Ye T, Dai B, Zhang J, et al
    Sex-specific patterns in tau spreading throughout the Braak stages in the Alzheimer's disease spectrum.
    J Alzheimers Dis. 2026 Jan 13:13872877251406131. doi: 10.1177/13872877251406131.
    PubMed         Abstract available
    
    
28. ABEDIN MJ, Kastanenka KV
    The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential.
    J Alzheimers Dis. 2026 Jan 13:13872877251411561. doi: 10.1177/13872877251411561.
    PubMed         Abstract available
    
    

    
    J Neurosci

29. SLOAND TJ, Dunham BP, Niedringhaus M, West EA, et al
    Aberrant medial prefrontal cortex activity and flexible behavior in the TgF344-AD rat model of Alzheimer's disease.
    J Neurosci. 2026 Jan 13:e1387252026. doi: 10.1523/JNEUROSCI.1387-25.2026.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

30. NAGARAJAN V, Libowitz CL, Ackley BD, Wolfe MS, et al
    A C. elegans model of familial Alzheimer's disease shows age-dependent synaptic degeneration independent of amyloid beta-peptide.
    Neurobiol Dis. 2026;219:107267.
    PubMed         Abstract available
    
    
31. HUANG J, Rehman H, Doan C, Stein TD, et al
    Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.
    Neurobiol Dis. 2026 Jan 13:107257. doi: 10.1016/j.nbd.2026.107257.
    PubMed         Abstract available
    
    

    
    Neuroscience

32. BAJINKA O, Jallow L, Ozdemir G
    A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.
    Neuroscience. 2026 Jan 9:S0306-4522(26)00016.
    PubMed         Abstract available
    
    

    
    PLoS One

33. ZAHEDIPOUR M, Saniee Abadeh M, Shojaei S
    Alzheimer's disease prediction via an explainable CNN using genetic algorithm and SHAP values.
    PLoS One. 2026;21:e0337800.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum